Can-Fite in $9-million registered direct offering


Can-Fite BioPharma (NYSE MKT:CANF; TASE:CFBI) has entered into definitive agreements with institutional investors to raise $9-million through the sale of 2,068,966 American Depository Shares (ADS) at a price of $4.35 each in a registered direct offering.

For each ADS purchased, investors will receive an unregistered warrant to purchase one-half of an ADS. The warrants have an exercise price of $5.25 each, will be exercisable six months following the issuance date and will expire in five and one-half years.

Closing is set for Sept. 23. H.C. Wainwright is acting as the exclusive placement agent for the offering.

Sign up for the BioTuesdays weekly newsletter

Get the latest news on the healthcare industry’s corporate and clinical developments, executive moves, and market updates. Every Tuesday, in your inbox.